·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ´ëÀü½Ã¾à, ÃÖ±¤ÈÆ È¸Àå ÃÊû FAPA ¼³¸íȸ °¡Á® ±â»çÀÔ·Â : 24.06.11 17:56:21 0 °¡ ÇÃÄ£Ãß°¡ "¼º°øÀûÀÎ FAPA °³ÃÖ¿¡ Èû º¸Å°ڴÙ" [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ´ëÀü½Ã¾à»çȸ(ȸÀå Â÷¿ëÀÏ)°¡ ÃÖ±¤ÈÆ ´ëÇѾà»çȸÀåÀ» ÃÊûÇØ ¾Æ½Ã¾Æ¾àÇп¬¸Í(FAPA) ¼³¸íȸ ¹× Á¤Ã¥°£´ãȸ¸¦ ÁøÇàÇß´Ù. 10ÀÏ ¿¸° °£´ãȸ¿¡¼ ÃÖ±¤ÈÆ È¸ÀåÀº À̹ø FAPA ¼¿ïÃÑȸ ÁÖÁ¦°¡ '¾Æ½Ã¾ÆÀÇ Â÷¼¼´ë ¾à»ç'ÀÓÀ» °Á¶Çϸç, ¼¿ïÃÑȸ°¡ ¾à»çÀÇ ¹Ì·¡¸¦ ²Þ²Ù´Â ¾Æ½Ã¾Æ ¾à»çÀÇ ÃàÁ¦°¡ µÉ ¼ö ÀÖµµ·Ï ÃÖ¼±ÀÇ ³ë·ÂÀ» ´ÙÇÏ°Ú´Ù°í ¾à¼ÓÇß´Ù. ƯÈ÷ À̹ø ÃÑȸ´Â FAPA ⸳ 60ÁÖ³âÀ» ¸ÂÀÌÇÏ´Â ±â³äºñÀû Çà»çÀÓÀ» °Á¶ÇÏ¸ç ´ëÀü½Ã¾à»çȸ¿Í ȸ¿øµéÀÇ Âü¿©¸¦ ´çºÎÇß´Ù. ¾Æ¿ï·¯ ÃÖ±¤ÈÆ È¸ÀåÀº ÀǾàÇ° ¼ö±Þ ºÒ¾ÈÁ¤°ú ºñ´ë¸é Áø·á ½Ã¹ü»ç¾÷ ¹× ¾à ¹è´Þ ¹Ý´ë, °øÀû ÀüÀÚó¹æÀü Àü´Þ½Ã½ºÅÛ ±¸Ãà, ºÒ¹ý¡¤Æí¹ý ¾à±¹°³¼³ ±ÙÀý ¹× °ü¸®°È µî ¾à»çȸ Á¤Ã¥¿¡ ´ëÇؼµµ ¼³¸íÇÏ´Â ½Ã°£À» °¡Á³´Ù. ÀÌ¿¡ Â÷¿ëÀÏ È¸ÀåÀº "´ëÀü½Ã¾à»çȸ°¡ Àû±ØÀûÀ¸·Î Âü¿©¸¦ µ¶·ÁÇÏ°í, ¼º°øÀûÀÎ FAPA °³ÃÖ¸¦ À§ÇØ ÈûÀ» º¸Å°ڴÙ"°í È´äÇß´Ù. °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] º´¿ø¿µ¾÷ ä¿ë¿¬°èÇü ÀÎÅÏ(½ÅÀÔ) ¸ðÁý ¹Ù·Î°¡±â »ç¾÷(º»)ºÎº°(CS ¾à»ç ºÎ¹® µî) ä¿ë ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) Ç°Áú°ü¸®Ã¥ÀÓ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â PV(¾à¹°°¨½Ã) & RA(ÀÎÇã°¡) ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ(¾à»ç), PV(¾à¹°°¨½Ã) ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â Clinical Trial Monitor ¹Ù·Î°¡±â Product Manager (Á¤±ÔÁ÷) ¹Ù·Î°¡±â Çѱ¹·Î½´ Clinical Operations Lead ¹Ù·Î°¡±â MSL / ºòµ¥ÀÌÅÍ / ITº¸¾È / °ø¹« / ±â¼ú±³Á¤ / »ý»ê / SFE ¹Ù·Î°¡±â Á¦Á¶°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¼öÀÔ°ü¸®ÀÚ ¾à»ç ¸ðÁý ¹Ù·Î°¡±â [CSL Behring] ȯÀÚ¼Ö·ç¼Ç ¹× ´ë¿ÜÇù·Â(Sr. Manager) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´ëÀü½Ã¾à, ÃÖ±¤ÈÆ È¸Àå ÃÊû FAPA ¼³¸íȸ °¡Á® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ´ëÀü½Ã¾à, ÃÖ±¤ÈÆ È¸Àå ÃÊû FAPA ¼³¸íȸ °¡Á® ±â»çÀÔ·Â : 24.06.11 17:56:21 0 °¡ ÇÃÄ£Ãß°¡ "¼º°øÀûÀÎ FAPA °³ÃÖ¿¡ Èû º¸Å°ڴÙ" [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ´ëÀü½Ã¾à»çȸ(ȸÀå Â÷¿ëÀÏ)°¡ ÃÖ±¤ÈÆ ´ëÇѾà»çȸÀåÀ» ÃÊûÇØ ¾Æ½Ã¾Æ¾àÇп¬¸Í(FAPA) ¼³¸íȸ ¹× Á¤Ã¥°£´ãȸ¸¦ ÁøÇàÇß´Ù. 10ÀÏ ¿¸° °£´ãȸ¿¡¼ ÃÖ±¤ÈÆ È¸ÀåÀº À̹ø FAPA ¼¿ïÃÑȸ ÁÖÁ¦°¡ '¾Æ½Ã¾ÆÀÇ Â÷¼¼´ë ¾à»ç'ÀÓÀ» °Á¶Çϸç, ¼¿ïÃÑȸ°¡ ¾à»çÀÇ ¹Ì·¡¸¦ ²Þ²Ù´Â ¾Æ½Ã¾Æ ¾à»çÀÇ ÃàÁ¦°¡ µÉ ¼ö ÀÖµµ·Ï ÃÖ¼±ÀÇ ³ë·ÂÀ» ´ÙÇÏ°Ú´Ù°í ¾à¼ÓÇß´Ù. ƯÈ÷ À̹ø ÃÑȸ´Â FAPA ⸳ 60ÁÖ³âÀ» ¸ÂÀÌÇÏ´Â ±â³äºñÀû Çà»çÀÓÀ» °Á¶ÇÏ¸ç ´ëÀü½Ã¾à»çȸ¿Í ȸ¿øµéÀÇ Âü¿©¸¦ ´çºÎÇß´Ù. ¾Æ¿ï·¯ ÃÖ±¤ÈÆ È¸ÀåÀº ÀǾàÇ° ¼ö±Þ ºÒ¾ÈÁ¤°ú ºñ´ë¸é Áø·á ½Ã¹ü»ç¾÷ ¹× ¾à ¹è´Þ ¹Ý´ë, °øÀû ÀüÀÚó¹æÀü Àü´Þ½Ã½ºÅÛ ±¸Ãà, ºÒ¹ý¡¤Æí¹ý ¾à±¹°³¼³ ±ÙÀý ¹× °ü¸®°È µî ¾à»çȸ Á¤Ã¥¿¡ ´ëÇؼµµ ¼³¸íÇÏ´Â ½Ã°£À» °¡Á³´Ù. ÀÌ¿¡ Â÷¿ëÀÏ È¸ÀåÀº "´ëÀü½Ã¾à»çȸ°¡ Àû±ØÀûÀ¸·Î Âü¿©¸¦ µ¶·ÁÇÏ°í, ¼º°øÀûÀÎ FAPA °³ÃÖ¸¦ À§ÇØ ÈûÀ» º¸Å°ڴÙ"°í È´äÇß´Ù. °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç [Çѱ¹¿ÀÃ÷Ä«Á¦¾à] º´¿ø¿µ¾÷ ä¿ë¿¬°èÇü ÀÎÅÏ(½ÅÀÔ) ¸ðÁý ¹Ù·Î°¡±â »ç¾÷(º»)ºÎº°(CS ¾à»ç ºÎ¹® µî) ä¿ë ¹Ù·Î°¡±â ±¹Á¦¾àÇ°(ÁÖ) Ç°Áú°ü¸®Ã¥ÀÓ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â PV(¾à¹°°¨½Ã) & RA(ÀÎÇã°¡) ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ(¾à»ç), PV(¾à¹°°¨½Ã) ¹Ù·Î°¡±â °æ·ÂÁ÷ MRä¿ë (¼öµµ±Ç) ¹Ù·Î°¡±â [»ï¿ø¾àÇ° ¿ï»êÁöÁ¡] °ü¸®¾à»ç´Ô ¸ðÁý°ø°í ¹Ù·Î°¡±â Clinical Trial Monitor ¹Ù·Î°¡±â Product Manager (Á¤±ÔÁ÷) ¹Ù·Î°¡±â Çѱ¹·Î½´ Clinical Operations Lead ¹Ù·Î°¡±â MSL / ºòµ¥ÀÌÅÍ / ITº¸¾È / °ø¹« / ±â¼ú±³Á¤ / »ý»ê / SFE ¹Ù·Î°¡±â Á¦Á¶°ü¸® ¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¼öÀÔ°ü¸®ÀÚ ¾à»ç ¸ðÁý ¹Ù·Î°¡±â [CSL Behring] ȯÀÚ¼Ö·ç¼Ç ¹× ´ë¿ÜÇù·Â(Sr. Manager) ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´ëÀü½Ã¾à, ÃÖ±¤ÈÆ È¸Àå ÃÊû FAPA ¼³¸íȸ °¡Á® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ´ëÀü½Ã¾à, ÃÖ±¤ÈÆ È¸Àå ÃÊû FAPA ¼³¸íȸ °¡Á® ±â»çÀÔ·Â : 24.06.11 17:56:21 0 °¡ ÇÃÄ£Ãß°¡ "¼º°øÀûÀÎ FAPA °³ÃÖ¿¡ Èû º¸Å°ڴÙ" [µ¥Àϸ®ÆÊ=°Çý°æ ±âÀÚ] ´ëÀü½Ã¾à»çȸ(ȸÀå Â÷¿ëÀÏ)°¡ ÃÖ±¤ÈÆ ´ëÇѾà»çȸÀåÀ» ÃÊûÇØ ¾Æ½Ã¾Æ¾àÇп¬¸Í(FAPA) ¼³¸íȸ ¹× Á¤Ã¥°£´ãȸ¸¦ ÁøÇàÇß´Ù. 10ÀÏ ¿¸° °£´ãȸ¿¡¼ ÃÖ±¤ÈÆ È¸ÀåÀº À̹ø FAPA ¼¿ïÃÑȸ ÁÖÁ¦°¡ '¾Æ½Ã¾ÆÀÇ Â÷¼¼´ë ¾à»ç'ÀÓÀ» °Á¶Çϸç, ¼¿ïÃÑȸ°¡ ¾à»çÀÇ ¹Ì·¡¸¦ ²Þ²Ù´Â ¾Æ½Ã¾Æ ¾à»çÀÇ ÃàÁ¦°¡ µÉ ¼ö ÀÖµµ·Ï ÃÖ¼±ÀÇ ³ë·ÂÀ» ´ÙÇÏ°Ú´Ù°í ¾à¼ÓÇß´Ù. ƯÈ÷ À̹ø ÃÑȸ´Â FAPA ⸳ 60ÁÖ³âÀ» ¸ÂÀÌÇÏ´Â ±â³äºñÀû Çà»çÀÓÀ» °Á¶ÇÏ¸ç ´ëÀü½Ã¾à»çȸ¿Í ȸ¿øµéÀÇ Âü¿©¸¦ ´çºÎÇß´Ù. ¾Æ¿ï·¯ ÃÖ±¤ÈÆ È¸ÀåÀº ÀǾàÇ° ¼ö±Þ ºÒ¾ÈÁ¤°ú ºñ´ë¸é Áø·á ½Ã¹ü»ç¾÷ ¹× ¾à ¹è´Þ ¹Ý´ë, °øÀû ÀüÀÚó¹æÀü Àü´Þ½Ã½ºÅÛ ±¸Ãà, ºÒ¹ý¡¤Æí¹ý ¾à±¹°³¼³ ±ÙÀý ¹× °ü¸®°È µî ¾à»çȸ Á¤Ã¥¿¡ ´ëÇؼµµ ¼³¸íÇÏ´Â ½Ã°£À» °¡Á³´Ù. ÀÌ¿¡ Â÷¿ëÀÏ È¸ÀåÀº "´ëÀü½Ã¾à»çȸ°¡ Àû±ØÀûÀ¸·Î Âü¿©¸¦ µ¶·ÁÇÏ°í, ¼º°øÀûÀÎ FAPA °³ÃÖ¸¦ À§ÇØ ÈûÀ» º¸Å°ڴÙ"°í È´äÇß´Ù. °Çý°æ ±âÀÚ(khk@dailypharm.com ) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ´ëÀü½Ã¾à, ÃÖ±¤ÈÆ È¸Àå ÃÊû FAPA ¼³¸íȸ °¡Á® URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö